Quantum Leap Healthcare Collaborative

"Separating contenders from
pretenders in breast cancer"

-- ASCO Post

"Blazes a trail in breast cancer"

-- Nature Biotechnology

"A glimpse into the future of
phase II drug development?"

I-SPY Email List Sign-up
I-SPY  PATIENT INFORMATION SITE. Visit: www.ispypatient.org

Featured News

What is I-SPY?

The I-SPY series of trials are changing the way new treatments are developed for breast cancer, helping make available new, better and more personalized treatments, faster. At the heart of the I-SPY program is the ground-breaking I-SPY 2 platform trial for neoadjuvant treatment of locally advanced breast cancer.

patients enrolled
agents completed
evaluation since 2010
agents received
accelerated approval
Find out more

World-class science requires world-class scientists

Meet some of our team

I-SPY is supported by:

I-SPY Sponsor:
Quantum Leap Healthcare Collaborative